Kenvue shares rose in premarket trading Tuesday, rebounding after a record low the day before, even as U.S. President Donald Trump linked Tylenol to autism risk during pregnancy at a White House press ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback